<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Sara Lee Corporation</title>
	<atom:link href="http://www.stockbloghub.com/tag/sara-lee-corporation/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(HUM) Attention Shifts to Jobs &#8211; Earnings Preview</title>
		<link>http://www.stockbloghub.com/2012/04/28/hum-attention-shifts-to-jobs-earnings-preview/99859</link>
		<comments>http://www.stockbloghub.com/2012/04/28/hum-attention-shifts-to-jobs-earnings-preview/99859#comments</comments>
		<pubDate>Sat, 28 Apr 2012 20:04:34 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ADM]]></category>
		<category><![CDATA[ADP]]></category>
		<category><![CDATA[AIG]]></category>
		<category><![CDATA[ALL]]></category>
		<category><![CDATA[Allstate Corporation]]></category>
		<category><![CDATA[AM]]></category>
		<category><![CDATA[American Greetings Corporation]]></category>
		<category><![CDATA[American International Group Inc]]></category>
		<category><![CDATA[Archer-Daniels-Midland Company]]></category>
		<category><![CDATA[Automatic Data Processing Inc]]></category>
		<category><![CDATA[Avon Products Inc.]]></category>
		<category><![CDATA[AVP]]></category>
		<category><![CDATA[Cablevision Systems Corporation]]></category>
		<category><![CDATA[CBS]]></category>
		<category><![CDATA[CBS Corporation]]></category>
		<category><![CDATA[CMCSA]]></category>
		<category><![CDATA[Comcast Corporation]]></category>
		<category><![CDATA[CVC]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[EL]]></category>
		<category><![CDATA[Estee Lauder Companies Inc.]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[L]]></category>
		<category><![CDATA[Loews Corporation]]></category>
		<category><![CDATA[MA]]></category>
		<category><![CDATA[Mastercard Incorporated]]></category>
		<category><![CDATA[Nyse Euronext Inc]]></category>
		<category><![CDATA[NYX]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[Time Warner Inc.]]></category>
		<category><![CDATA[TWX]]></category>
		<category><![CDATA[V]]></category>
		<category><![CDATA[VIAB]]></category>
		<category><![CDATA[Viacom]]></category>
		<category><![CDATA[Visa Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=99859</guid>
		<description><![CDATA[Earnings Preview – Week of April 30th The focus this week will be on the labor market, with the April non-farm payroll report coming out on Friday. Many will be hoping that this report will provide confirmation that last month’s disappointment was just a one-off event and the positive trend line of the preceding months is still in place. Jobs aside, we are still in the midst of the first quarter 2012 reporting season, though we have crossed the mid-point of the cycle with about 60% of the results already in. With another 124 S&#38;P 500 companies reporting results in the coming week, we will have results from roughly 84% of the companies by the end of this week. The first quarter earnings season has turned out to be much ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/28/hum-attention-shifts-to-jobs-earnings-preview/99859/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences Analyst Still Neutral on Shares</title>
		<link>http://www.stockbloghub.com/2012/04/02/hgsi-human-genome-sciences-analyst-still-neutral-on-shares/97209</link>
		<comments>http://www.stockbloghub.com/2012/04/02/hgsi-human-genome-sciences-analyst-still-neutral-on-shares/97209#comments</comments>
		<pubDate>Mon, 02 Apr 2012 17:37:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=97209</guid>
		<description><![CDATA[We are maintaining our Neutral recommendation on Human Genome Sciences Inc. (HGSI) with a target price of $8.25. Human Genome, founded in 1992 and based in Rockville, Maryland, is a biopharmaceutical company. The US launch of Benlysta in March 2011 for treating patients suffering from systemic lupus erythematosus (SLE) was a huge positive for Human Genome. The subsequent launch of the drug in Canada and several European nations, including Germany, Spain, Austria, Denmark, Finland, Hungary, Norway and Sweden is also encouraging. Benlysta, which has blockbuster potential, has been co-developed with GlaxoSmithKline (GSK). Benlysta is the first new lupus drug to be cleared in more than 50 years. Sales of the drug are growing, albeit slowly. Net sales of Benlysta improved 36.7% sequentially to $25.7 million in the final quarter of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/02/hgsi-human-genome-sciences-analyst-still-neutral-on-shares/97209/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(KO) Consumer Staples Sector Outlook &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2012/03/28/ko-consumer-staples-sector-outlook-industry-outlook/96695</link>
		<comments>http://www.stockbloghub.com/2012/03/28/ko-consumer-staples-sector-outlook-industry-outlook/96695#comments</comments>
		<pubDate>Wed, 28 Mar 2012 15:47:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Beverages - Soft Drinks]]></category>
		<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Altria Group Inc.]]></category>
		<category><![CDATA[Avon Products Inc.]]></category>
		<category><![CDATA[AVP]]></category>
		<category><![CDATA[HJ Heinz Company]]></category>
		<category><![CDATA[HNZ]]></category>
		<category><![CDATA[K]]></category>
		<category><![CDATA[Kellogg Company]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kimberly-Clark Corporation]]></category>
		<category><![CDATA[KMB]]></category>
		<category><![CDATA[KO]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[MO]]></category>
		<category><![CDATA[PEP]]></category>
		<category><![CDATA[Pepsico Inc.]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Philip Morris International Inc]]></category>
		<category><![CDATA[PM]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SJM]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[SUPERVALU Inc.]]></category>
		<category><![CDATA[SVU]]></category>
		<category><![CDATA[The Coca-Cola Company]]></category>
		<category><![CDATA[The J. M. Smucker Company]]></category>
		<category><![CDATA[UL]]></category>
		<category><![CDATA[Unilever plc]]></category>
		<category><![CDATA[Wal-Mart Stores Inc.]]></category>
		<category><![CDATA[WMT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=96695</guid>
		<description><![CDATA[Stocks in the Consumer Staples sector carried out their traditional defensive role as the broader equity markets came under pressure over concerns about the prolonged weak US economy and the debt crisis in Europe. But the group has been a laggard as momentum returned to the market over the last three months. In 2011, the sector index grew 10.5% versus a flat finish for the S&#38;P 500 index. The group’s defensive attributes stem from its ability to buck sluggish economic growth as food, beverage, household products and cosmetics companies that manufacture and market non-durable consumables are considered essential to daily life, such as food, drink, toothpaste, deodorants, toilet paper, etc. Although staples’ top-line is expected to continue the uptrend of the last few quarters going forward, margins will remain under ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/28/ko-consumer-staples-sector-outlook-industry-outlook/96695/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DTG) Company News for December 13, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/12/13/dtg-company-news-for-december-13-2011-corporate-summary/88499</link>
		<comments>http://www.stockbloghub.com/2011/12/13/dtg-company-news-for-december-13-2011-corporate-summary/88499#comments</comments>
		<pubDate>Tue, 13 Dec 2011 18:37:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Rental & Leasing Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Cheniere Energy Inc]]></category>
		<category><![CDATA[Dollar Thrifty Automotive Group Inc]]></category>
		<category><![CDATA[DTG]]></category>
		<category><![CDATA[Endo Pharmaceuticals Holdings Inc]]></category>
		<category><![CDATA[ENDP]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[LNG]]></category>
		<category><![CDATA[Martin Marietta Materials Inc.]]></category>
		<category><![CDATA[MLM]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[VMC]]></category>
		<category><![CDATA[Vulcan Materials Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88499</guid>
		<description><![CDATA[•    Car rental company Dollar Thrifty Automotive Group (NYSE:DTG) said the company&#8217;s CEO and President Mr. Scott L. Thompson will take over the role of Chairman of the Board of Directors with immediate effect. He succeeds Richard W Neu who will assume the role of Lead Independent Director •    Food and beverage company Sara Lee (NYSE:SLE) announced it had purchased Amsterdam based beverage chain CoffeeCompany which consists of 35 cafe bars •    Shares of energy company Cheniere Energy Inc. (AMEX:LNG) gained 5.46% a share after one of the company&#8217;s subsidiary concluded an agreement to sell natural gas to Indian gas transmission and marketing company Gail Ltd •    Drug maker Endo Pharmaceuticals Holdings Inc.’s (NASDAQ:ENDP) share prices increased 5.97%  to close at $36.04 after the company said U.S. Food and Drug ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/13/dtg-company-news-for-december-13-2011-corporate-summary/88499/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(KO) Consumer Staples Stock Outlook &#8211; December 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/12/08/ko-consumer-staples-stock-outlook-december-2011-industry-outlook/88225</link>
		<comments>http://www.stockbloghub.com/2011/12/08/ko-consumer-staples-stock-outlook-december-2011-industry-outlook/88225#comments</comments>
		<pubDate>Thu, 08 Dec 2011 17:08:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Beverages - Soft Drinks]]></category>
		<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[HJ Heinz Company]]></category>
		<category><![CDATA[HNZ]]></category>
		<category><![CDATA[K]]></category>
		<category><![CDATA[Kellogg Company]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kimberly-Clark Corporation]]></category>
		<category><![CDATA[KMB]]></category>
		<category><![CDATA[KO]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[LO]]></category>
		<category><![CDATA[Lorillard Inc.]]></category>
		<category><![CDATA[PEP]]></category>
		<category><![CDATA[Pepsico Inc.]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[SUPERVALU Inc.]]></category>
		<category><![CDATA[SVU]]></category>
		<category><![CDATA[The Coca-Cola Company]]></category>
		<category><![CDATA[UL]]></category>
		<category><![CDATA[Unilever plc]]></category>
		<category><![CDATA[Wal-Mart Stores Inc.]]></category>
		<category><![CDATA[WMT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88225</guid>
		<description><![CDATA[Stocks in the Consumer Staples sector performed their traditional defensive role as the broader equity markets came under pressure over concerns about the prolonged weak U.S. economy and the debt crisis in Europe. Shares of consumer staples companies, accounting for a total of about 11.4% of the S&#38;P 500 Index, were up 5.3%, compared with a 3.3% drop for the S&#38;P 500. In 2010, the sector index grew 10.7% versus a 12.8% increase for the S&#38;P 500 index. The consumer staples companies are typically able to buck sluggish economic growth as food, beverage, household products and cosmetics companies that manufacture and market non-durable consumables, are considered essential to daily life, such as food, drink, toothpaste, deodorants, toilet paper, etc. Although, staples’ earnings are expected to the continue the uptrend of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/08/ko-consumer-staples-stock-outlook-december-2011-industry-outlook/88225/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HRL) Snack-On: Hormel in the Menu</title>
		<link>http://www.stockbloghub.com/2011/11/30/hrl-snack-on-hormel-in-the-menu/87710</link>
		<comments>http://www.stockbloghub.com/2011/11/30/hrl-snack-on-hormel-in-the-menu/87710#comments</comments>
		<pubDate>Wed, 30 Nov 2011 19:53:34 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Meat Products]]></category>
		<category><![CDATA[Hormel Foods Corporation]]></category>
		<category><![CDATA[HRL]]></category>
		<category><![CDATA[K]]></category>
		<category><![CDATA[Kellogg Company]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[TSN]]></category>
		<category><![CDATA[Tyson Foods Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87710</guid>
		<description><![CDATA[According to New York Times- Americans eat 31% more packaged food than fresh food and they consume more packaged food per person than their counterparts in nearly all other countries. A sizable part of the American diet is ready-to-eat meals, like frozen pizzas and microwave dinners and sweet or salty snack foods. This probably doesn&#8217;t come as a surprise, given the country’s obesity rates. However, the surprise lies in analysts assigning a camouflaged tone of under-weight to these processed and packaged food company stocks, which has been dwindling investor confidence over quite some time. Is Hormel Foods Corp (HRL) a prey to such a confusing situation? The Industry Hitch The trouble with quality food companies is that they rarely get cheap and when they do, they often erode away the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/30/hrl-snack-on-hormel-in-the-menu/87710/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MS) Oct 19: The Earnings Parade Continues &#8211; Economic Highlights</title>
		<link>http://www.stockbloghub.com/2011/10/20/ms-oct-19-the-earnings-parade-continues-economic-highlights/85423</link>
		<comments>http://www.stockbloghub.com/2011/10/20/ms-oct-19-the-earnings-parade-continues-economic-highlights/85423#comments</comments>
		<pubDate>Thu, 20 Oct 2011 14:44:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Investments]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[ConocoPhillips]]></category>
		<category><![CDATA[COP]]></category>
		<category><![CDATA[CSX]]></category>
		<category><![CDATA[CSX Corporation]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[EBAY]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[Marathon Oil Corporation]]></category>
		<category><![CDATA[MHP]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MRO]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[The McGraw-Hill Companies Inc]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[UTX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85423</guid>
		<description><![CDATA[The earnings parade continues even as the market tries to come to terms with the Apple surprise and waits for the expected weekend deal out of Europe. We also have economic data this morning about September CPI and Housing Starts, but they will likely have less traction in today&#8217;s market given the focus on earnings and Europe. The September CPI number was largely inline expectations, both on the &#8216;headline&#8217; as well as &#8216;core&#8217; basis. Given the recent pullback in commodity prices and the continued slack in the broader economy, inflation will likely have less staying power than would otherwise be the case. However, persistent &#8216;hot&#8217; CPI readings will make it difficult for Bernanke to rally all FOMC members behind him as we have seen in recent meetings. The Fed dissenters ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/20/ms-oct-19-the-earnings-parade-continues-economic-highlights/85423/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MS) Ahead of Wall Street &#8211; October 19, 2011 &#8211; Ahead of Wall Street</title>
		<link>http://www.stockbloghub.com/2011/10/20/ms-ahead-of-wall-street-october-19-2011-ahead-of-wall-street/85469</link>
		<comments>http://www.stockbloghub.com/2011/10/20/ms-ahead-of-wall-street-october-19-2011-ahead-of-wall-street/85469#comments</comments>
		<pubDate>Thu, 20 Oct 2011 14:44:31 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Investments]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[ConocoPhillips]]></category>
		<category><![CDATA[COP]]></category>
		<category><![CDATA[CSX]]></category>
		<category><![CDATA[CSX Corporation]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[EBAY]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[Marathon Oil Corporation]]></category>
		<category><![CDATA[MHP]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MRO]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[The McGraw-Hill Companies Inc]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[UTX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85469</guid>
		<description><![CDATA[Wednesday, October 19, 2011 The earnings parade continues even as the market tries to come to terms with the Apple surprise and waits for the expected weekend deal out of Europe. We also have economic data this morning about September CPI and Housing Starts, but they will likely have less traction in today&#8217;s market given the focus on earnings and Europe. The September CPI number was largely inline expectations, both on the &#8216;headline&#8217; as well as &#8216;core&#8217; basis. Given the recent pullback in commodity prices and the continued slack in the broader economy, inflation will likely have less staying power than would otherwise be the case. However, persistent &#8216;hot&#8217; CPI readings will make it difficult for Bernanke to rally all FOMC members behind him as we have seen in recent ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/20/ms-ahead-of-wall-street-october-19-2011-ahead-of-wall-street/85469/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CL) Consumer Staples Stock Outlook &#8211; October 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/10/17/cl-consumer-staples-stock-outlook-october-2011-industry-outlook/85086</link>
		<comments>http://www.stockbloghub.com/2011/10/17/cl-consumer-staples-stock-outlook-october-2011-industry-outlook/85086#comments</comments>
		<pubDate>Mon, 17 Oct 2011 15:44:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Personal Products]]></category>
		<category><![CDATA[Altria Group Inc.]]></category>
		<category><![CDATA[Avon Products Inc.]]></category>
		<category><![CDATA[AVP]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Colgate-Palmolive Company]]></category>
		<category><![CDATA[FRED]]></category>
		<category><![CDATA[Fred's Inc.]]></category>
		<category><![CDATA[HJ Heinz Company]]></category>
		<category><![CDATA[HNZ]]></category>
		<category><![CDATA[Kimberly-Clark Corporation]]></category>
		<category><![CDATA[KMB]]></category>
		<category><![CDATA[MO]]></category>
		<category><![CDATA[PEP]]></category>
		<category><![CDATA[Pepsico Inc.]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Philip Morris International Inc]]></category>
		<category><![CDATA[PM]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[SUPERVALU Inc.]]></category>
		<category><![CDATA[SVU]]></category>
		<category><![CDATA[UL]]></category>
		<category><![CDATA[Unilever plc]]></category>
		<category><![CDATA[Wal-Mart Stores Inc.]]></category>
		<category><![CDATA[WMT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85086</guid>
		<description><![CDATA[Stocks in the Consumer Staples sector performed their traditional defensive role as the broader equity markets came under pressure in response to concerns over Europe’s sovereign debt crisis and a weak U.S. economy. The fundamental explanation is that food, beverage, household products and cosmetics companies that manufacture and market consumable products, most of which are considered essential to daily life, such as food, drink, toothpaste, deodorants, toilet paper, etc. As of September 18, 2011 the consumer staples sector represented 11.8% of the S&#38;P 500 Index, up 0.4%, compared with a 10.7% drop for the S&#38;P 500. In 2010, the sector index grew 10.7% versus a 12.8% increase for the S&#38;P 500 index. But with the market shifting gear and starting to move up again over the last few trading sessions, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/17/cl-consumer-staples-stock-outlook-october-2011-industry-outlook/85086/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Corporation &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2011/09/26/sle-sara-lee-corporation-bear-of-the-day-2/84057</link>
		<comments>http://www.stockbloghub.com/2011/09/26/sle-sara-lee-corporation-bear-of-the-day-2/84057#comments</comments>
		<pubDate>Mon, 26 Sep 2011 19:26:26 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84057</guid>
		<description><![CDATA[We have downgraded the recommendation of Sara Lee Corp. (SLE) to Underperform from Neutral as the company remains under tremendous inflationary pressure, further burdened by severe competition from several branded and private label products. Though the company is making efforts to combat its rising price of coffee and meat by raising prices, we believe that the company has to sacrifice volume in the process. The company is also undertaking strategic dis-investments to cope with higher expenses. The company is also planning to split itself into two businesses. However, we remain skeptical as the spin-off is subject to clearance from several regulations. Though Sara Lee&#8217;s fourth quarter 2011 earnings of $0.20 was decently ahead of the year-ago period and was in-line with the Zacks Consensus Estimate, we do not see any ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/26/sle-sara-lee-corporation-bear-of-the-day-2/84057/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences Analyst Maintains Neutral Recommendation</title>
		<link>http://www.stockbloghub.com/2011/08/22/hgsi-human-genome-sciences-analyst-maintains-neutral-recommendation/81747</link>
		<comments>http://www.stockbloghub.com/2011/08/22/hgsi-human-genome-sciences-analyst-maintains-neutral-recommendation/81747#comments</comments>
		<pubDate>Mon, 22 Aug 2011 14:47:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Charles River Laboratories International Inc]]></category>
		<category><![CDATA[CRL]]></category>
		<category><![CDATA[EU]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[WisdomTree Dreyfus Euro]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=81747</guid>
		<description><![CDATA[We are maintaining our Neutral recommendation on Human Genome Sciences Inc. (HGSI) with a target price of $16.00. Human Genome, founded in 1992 and based in Rockville, Maryland, is a biopharmaceutical company. The US launch of Benlysta earlier in the year for treating patients suffering from systemic lupus erythematosus (SLE) is a huge positive for Human Genome. The subsequent approvals of the drug in the European Union (EU) and Canada are also encouraging. The drug, which has blockbuster potential, has been co-developed with GlaxoSmithKline (GSK). Benlysta is the first new lupus drug to be cleared in more than 50 years. Lupus is a potentially fatal autoimmune disease that is extremely difficult to treat. We believe that the approval of this potentially blockbuster candidate will drive Human Genome to profitability. Benlysta ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/22/hgsi-human-genome-sciences-analyst-maintains-neutral-recommendation/81747/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AAP) Company News for August 12, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/08/13/aap-company-news-for-august-12-2011-corporate-summary/81229</link>
		<comments>http://www.stockbloghub.com/2011/08/13/aap-company-news-for-august-12-2011-corporate-summary/81229#comments</comments>
		<pubDate>Sat, 13 Aug 2011 19:45:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Auto Parts Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAP]]></category>
		<category><![CDATA[Advance Auto Parts Inc.]]></category>
		<category><![CDATA[Capital One Financial Corporation]]></category>
		<category><![CDATA[COF]]></category>
		<category><![CDATA[Elizabeth Arden Inc.]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[GM]]></category>
		<category><![CDATA[PAAS]]></category>
		<category><![CDATA[Pan American Silver Corporation]]></category>
		<category><![CDATA[RDEN]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=81229</guid>
		<description><![CDATA[•    Pan American Silver Corp (NASDAQ:PAAS) posted Q2 EPS of $0.71, lower than the Zacks Consensus Estimate of $0.74 per share. Revenues rose 57.4% year-over-year to $231.9 million, missing the Zacks Consensus Estimate of $282.0 million •    FXCM (NASDAQ:FXCM) reported Q2 EPS of $0.19, which came in below the Zacks Consensus Estimate of $0.20 per share. Revenues for the quarter rose 9.2% year-over-year to $103.4 million, beating the Zacks Consensus Estimate of $78.0 million •    Motor company General Motors (NYSE:GM) announced that it has entered into a supply contact with battery maker A123 Systems, Inc. (NASDAQ:AONE) which will allow the company to sell batteries for GM&#8217;s future electric vehicles in global markets. Following this announcement, share prices of A123 Systems Inc. jumped 45.11% to close at $4.60 •    Share prices ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/13/aap-company-news-for-august-12-2011-corporate-summary/81229/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Pitches Hillshire to Women</title>
		<link>http://www.stockbloghub.com/2011/07/11/sle-sara-lee-pitches-hillshire-to-women/78615</link>
		<comments>http://www.stockbloghub.com/2011/07/11/sle-sara-lee-pitches-hillshire-to-women/78615#comments</comments>
		<pubDate>Mon, 11 Jul 2011 15:48:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[TSN]]></category>
		<category><![CDATA[Tyson Foods Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78615</guid>
		<description><![CDATA[Hillshire Farm, a popular brand of meat owned and marketed by Sara Lee Corporation (SLE), launches a new ad campaign ‘So Good, They&#8217;ll Think It&#8217;s For Them’ to attract the women customers and add to the success of the already existing ‘Go Meat’ tagline. Unlike the ‘Go Meat’ campaign which featured men in the backyards cheering for their Hillshire Farm sausage, the new commercial plays on the secret desires of women to be an excellent homemaker and care for their family by offering delicious and high-quality meals. The new commercial features popular Hollywood actors like McLendon-Coveyand is quite innovatively designed, keeping with Hillshire Farm’s tradition of great advertising. The commercial prompts women to use meat from Hillshire Farm and win over several other situations by offering a delicious meal. Advertisements ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/11/sle-sara-lee-pitches-hillshire-to-women/78615/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Finishes Eating Aidell&#8217;s Sausage Company</title>
		<link>http://www.stockbloghub.com/2011/07/01/sle-sara-lee-finishes-eating-aidells-sausage-company/78148</link>
		<comments>http://www.stockbloghub.com/2011/07/01/sle-sara-lee-finishes-eating-aidells-sausage-company/78148#comments</comments>
		<pubDate>Fri, 01 Jul 2011 16:45:04 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[TSN]]></category>
		<category><![CDATA[Tyson Foods Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78148</guid>
		<description><![CDATA[Sara Lee Corp. (SLE) announced that it has completed its $87 million buyout of Aidells Sausage Co. from Encore Consumer Capital, a private equity firm that invests exclusively in leading consumer products companies. The deal was originally announced on May 5, 2011. Sara Lee said the deal will help broaden its presence in the premium meats category and strengthen its North American meat business. Aidells pioneered the premium sausage category and offers a full product line of poultry-based products, such as Chicken &#38; Apple, Cajun Style Andouille and Roasted Garlic &#38; Gruyere Cheese sausages. Aidells also offers a line of meatball products in flavors such as Teriyaki Pineapple and Buffalo-Style. Management at Sara Lee also revealed that Aidells will form the cornerstone of the newly formed Gourmet Foods group within ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/01/sle-sara-lee-finishes-eating-aidells-sausage-company/78148/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CPB) Campbell Rewards Shareholders</title>
		<link>http://www.stockbloghub.com/2011/06/29/cpb-campbell-rewards-shareholders/77659</link>
		<comments>http://www.stockbloghub.com/2011/06/29/cpb-campbell-rewards-shareholders/77659#comments</comments>
		<pubDate>Wed, 29 Jun 2011 15:33:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Campbell Soup Company]]></category>
		<category><![CDATA[CPB]]></category>
		<category><![CDATA[General Mills Inc.]]></category>
		<category><![CDATA[GIS]]></category>
		<category><![CDATA[HJ Heinz Company]]></category>
		<category><![CDATA[HNZ]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77659</guid>
		<description><![CDATA[Campbell Soup Co. (CPB), diligent in rewarding shareholders, announced a share buyback of $1 billion sans expiration date. The new share buyback plan replaces the $1.2 billion which the company had announced in June 2008. To further accelerate shareholder value, the company also announced a regular quarterly dividend of 29 cents a share payable on August 1, 2011, to shareholders of record as on July 11, 2011. In a separate development, Campbell also named Denise Morrison as the President and Chief Executive Officer of the company. Denise will take over the reins, effective August 1, 2011, which is also the first day of Campbell’s next fiscal year. The 57 year old lady, Denise, will be the first woman executive to run the world’s largest soup company. Campbell Soup is one ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/29/cpb-campbell-rewards-shareholders/77659/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SFD) Smithfield to Explore Packaged Meat</title>
		<link>http://www.stockbloghub.com/2011/06/28/sfd-smithfield-to-explore-packaged-meat/77683</link>
		<comments>http://www.stockbloghub.com/2011/06/28/sfd-smithfield-to-explore-packaged-meat/77683#comments</comments>
		<pubDate>Tue, 28 Jun 2011 15:58:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Meat Products]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SFD]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[Smithfield Foods Inc.]]></category>
		<category><![CDATA[TSN]]></category>
		<category><![CDATA[Tyson Foods Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77683</guid>
		<description><![CDATA[Following the pull out from the acquisition deal of Spain’s Campofrio Food Group SA in June, Smithfield Foods Inc. (SFD) is now looking for potential opportunities in packaged-meats such as in smoked ham, bacon and frozen meatballs in an effort to enhance its brand value in the emerging markets. Currently, Smithfield is eyeing on Sara Lee Corp. (SLE), which is spinning off its beverage business to focus on meat. As an alternative, the company might get interested in China&#8217;s People’s Food Holdings Ltd., the world’s biggest consumer of pork and who has considerable amount of net cash and gets all its sales in China. Sara Lee Smithfield was always interested in the retail meats division of Sara Lee. In August 2006, Smithfield bagged Sara Lee’s European meats arm for $614 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/28/sfd-smithfield-to-explore-packaged-meat/77683/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CPB) Campbell&#8217;s Risk-Reward Balances</title>
		<link>http://www.stockbloghub.com/2011/06/19/cpb-campbells-risk-reward-balances/76730</link>
		<comments>http://www.stockbloghub.com/2011/06/19/cpb-campbells-risk-reward-balances/76730#comments</comments>
		<pubDate>Sun, 19 Jun 2011 13:32:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Campbell Soup Company]]></category>
		<category><![CDATA[CPB]]></category>
		<category><![CDATA[General Mills Inc.]]></category>
		<category><![CDATA[GIS]]></category>
		<category><![CDATA[HJ Heinz Company]]></category>
		<category><![CDATA[HNZ]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76730</guid>
		<description><![CDATA[We are maintaining a long-term &#8216;Neutral&#8217; recommendation on Campbell Soup Company (CPB) with a target price of $35.00 per share. Moreover, the company has a Zacks #3 Rank, implying a short-term &#8216;Hold&#8217; rating on the stock. Campbell Soup is one of the world&#8217;s leading manufacturers of convenience food products. Furthermore, a strong portfolio of well-established brands, including Campbell&#8217;s, Erasco, Liebig, Pepperidge Farm, V8, Pace, Prego, Swanson, and Arnott&#8217;s offer a competitive edge to the company and strengths its well-established position in the market. Moreover, management has been stimulating growth in the U.S. Soup, Sauces and Beverages business segment through investments in product quality, convenient packaging and introduction of new products. The company has also upgraded its marketing efforts and improved retail execution. These initiatives will facilitate in boosting the company&#8217;s ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/19/cpb-campbells-risk-reward-balances/76730/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SBUX) Starbucks Coffee Gets Expensive</title>
		<link>http://www.stockbloghub.com/2011/06/09/sbux-starbucks-coffee-gets-expensive/75340</link>
		<comments>http://www.stockbloghub.com/2011/06/09/sbux-starbucks-coffee-gets-expensive/75340#comments</comments>
		<pubDate>Thu, 09 Jun 2011 17:37:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Services]]></category>
		<category><![CDATA[Specialty Eateries]]></category>
		<category><![CDATA[PEET]]></category>
		<category><![CDATA[Peet's Coffee & Tea Inc.]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SBUX]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[Starbucks Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=75340</guid>
		<description><![CDATA[Starbucks Corp. (SBUX) replicated many coffee retailers by increasing the price of packaged coffee to combat the record 125 per cent steep climb in Arabica coffee prices. Starbucks recently raised its prices and announced a 17 per cent hike in the price of its packaged coffee. Analysts feel that among several factors that led to this abnormal hike in Arabica coffee futures the most important was a rush from coffee roasters such as Starbucks to hedge as much of its price exposure as possible. With the prospect of higher coffee prices on the horizon, Starbucks typically hedged two to three months ahead of its needs, according to traders. By January, Starbucks had fully hedged through the end of September which implied eight months ahead. In April, the company said it ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/09/sbux-starbucks-coffee-gets-expensive/75340/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PCLN) U.S. Jobs Report Better than Expected</title>
		<link>http://www.stockbloghub.com/2011/05/06/pcln-u-s-jobs-report-better-than-expected/73500</link>
		<comments>http://www.stockbloghub.com/2011/05/06/pcln-u-s-jobs-report-better-than-expected/73500#comments</comments>
		<pubDate>Sat, 07 May 2011 01:10:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Internet Information Providers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[Employment]]></category>
		<category><![CDATA[K]]></category>
		<category><![CDATA[Kellogg Company]]></category>
		<category><![CDATA[KFT]]></category>
		<category><![CDATA[Kraft Foods Inc.]]></category>
		<category><![CDATA[PCLN]]></category>
		<category><![CDATA[Priceline.com Inc]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[V]]></category>
		<category><![CDATA[Visa Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73500</guid>
		<description><![CDATA[The negative build-up over the last few days to today&#8217;s jobs report turned out to be completely off the mark. We got an impressive jobs report this morning, with the private sector coming up with one of its best showings in a long time. The Bureau of Labor Statistics reported the creation of 244,000 jobs in April, handily coming ahead of expectations. This is one of the best jobs report in a very long time. Importantly, the private sector added 268,000 jobs in April, up from the March tally of 231,000, with broad-based gains across all sectors. On the negative side, the unemployment rate jumped to 9% in April from 8.8% in March, reversing the rapid decline of the preceding months. Today&#8217;s report is the first positive indicator following a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/06/pcln-u-s-jobs-report-better-than-expected/73500/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COST) U.S. Jobless Claims Report Much Higher Than Anticipated</title>
		<link>http://www.stockbloghub.com/2011/05/05/cost-u-s-jobless-claims-report-much-higher-than-anticipated/73361</link>
		<comments>http://www.stockbloghub.com/2011/05/05/cost-u-s-jobless-claims-report-much-higher-than-anticipated/73361#comments</comments>
		<pubDate>Thu, 05 May 2011 13:43:31 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Discount Variety Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[COST]]></category>
		<category><![CDATA[Costco Wholesale Corporation]]></category>
		<category><![CDATA[Directv Group Inc]]></category>
		<category><![CDATA[DTV]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[Employment]]></category>
		<category><![CDATA[Gap Inc.]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[GM]]></category>
		<category><![CDATA[GPS]]></category>
		<category><![CDATA[Limited Brands Inc.]]></category>
		<category><![CDATA[LTD]]></category>
		<category><![CDATA[M]]></category>
		<category><![CDATA[Macy's Inc.]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[Target Corporation]]></category>
		<category><![CDATA[TGT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73361</guid>
		<description><![CDATA[The market is getting nervous about the economic recovery. Concerns that the first quarter softness may carry into the second quarter and beyond have been weighing on stocks lately. Economists have generally maintained their GDP growth forecasts at this stage. But softish economic readings, such as yesterday&#8217;s ISM/ADP and today&#8217;s Jobless Claims reports, increase the odds that we may start seeing those estimates start coming down in the coming days and weeks. It is with this nervous backdrop that the market is looking forward to tomorrow&#8217;s non-farm payroll report for April. In addition to some pockets of strength, particularly on the manufacturing side, the most reassuring sign on the recovery front has been the emerging signs of a labor market turnaround over the last few months. We may have to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/05/cost-u-s-jobless-claims-report-much-higher-than-anticipated/73361/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Corporation &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2011/02/17/sle-sara-lee-corporation-bear-of-the-day/67127</link>
		<comments>http://www.stockbloghub.com/2011/02/17/sle-sara-lee-corporation-bear-of-the-day/67127#comments</comments>
		<pubDate>Thu, 17 Feb 2011 15:18:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67127</guid>
		<description><![CDATA[Sara Lee Corp. (SLE) is a global manufacturer as well as marketer of high-quality brand products and possesses a formidable portfolio of well-established brands. However, as the company uses different commodities and raw materials, cost-push inflation remains a key risk factor. Further, with the intense competition prevailing in the branded food market, Sara Lee is constantly under pressure to maintain its position. In addition, after the resignation of Sara Lee&#8217;s Chairman and Chief Executive Officer Brenda Barnes and the divestiture of its North American bakery business, there are big questions going forward. Sara Lee is considering a sell-off itself to JBS, a Brazilian company. We currently downgrade the shares of Sara Lee from Neutral to Underperform. SARA LEE (SLE): Free Stock Analysis Report Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/17/sle-sara-lee-corporation-bear-of-the-day/67127/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HNZ) H.J. Heinz Company Second Quarter 2010 Earnings Preview</title>
		<link>http://www.stockbloghub.com/2010/11/25/hnz-h-j-heinz-company-second-quarter-2010-earnings-preview/59992</link>
		<comments>http://www.stockbloghub.com/2010/11/25/hnz-h-j-heinz-company-second-quarter-2010-earnings-preview/59992#comments</comments>
		<pubDate>Fri, 26 Nov 2010 04:42:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Food - Major Diversified]]></category>
		<category><![CDATA[Campbell Soup Company]]></category>
		<category><![CDATA[CPB]]></category>
		<category><![CDATA[HJ Heinz Company]]></category>
		<category><![CDATA[HNZ]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=59992</guid>
		<description><![CDATA[H.J. Heinz Company (HNZ), one of the leading manufacturer and marketer of processed food products worldwide, is scheduled to report its second-quarter 2011 financial results on Friday, November 19, 2010. The current Zacks Consensus Estimate for the quarter is 76 cents a share. First Quarter Synopsis The company posted robust earnings of 75 cents per share for the first quarter of fiscal 2011. The result was in line with the Zacks Consensus Estimate but came in ahead of the 68 cents per share recorded in the year-ago quarter. Profits were driven by strong performances in Emerging Markets and North American Consumer Products segments. During the quarter, Heinz recorded total sales growth of 1.6% to $2.48 billion from $2.44 billion in the prior-year quarter. The growth was primarily driven by a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/25/hnz-h-j-heinz-company-second-quarter-2010-earnings-preview/59992/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Corporation&#8217;s CEO Steps Down</title>
		<link>http://www.stockbloghub.com/2010/08/10/sle-sara-lee-corporations-ceo-steps-down/47224</link>
		<comments>http://www.stockbloghub.com/2010/08/10/sle-sara-lee-corporations-ceo-steps-down/47224#comments</comments>
		<pubDate>Tue, 10 Aug 2010 17:33:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[HOT]]></category>
		<category><![CDATA[PEP]]></category>
		<category><![CDATA[Pepsico]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[Starwood Hotels & Resorts Worldwide Inc]]></category>
		<category><![CDATA[The Cooper Companies Inc]]></category>
		<category><![CDATA[UL]]></category>
		<category><![CDATA[Unilever plc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=47224</guid>
		<description><![CDATA[Sara Lee Corp. (SLE) announced today that its CEO Brenda C. Barnes will resign from the positions of Chairman and Chief Executive Officer. She was on a prolonged medical leave since May 14, 2010 following a stroke. Under Barnes’ leadership, Sara Lee undertook various business restructuring initiatives. These included the sale of the company’s air freshener division to Procter &#38; Gamble (PG) and personal care brands to Unilever Plc. (UL) for a combined consideration of approximately $2.16 billion as well as efforts to bolster Sara Lee’s operations in high-growth emerging markets. Barnes joined Sara Lee in July 2004 as president and chief operating officer (COO) and became the chairman and CEO of the company in October 2005. Prior to joining Sara Lee, Barnes spent 22 years of her career with ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/10/sle-sara-lee-corporations-ceo-steps-down/47224/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PG) Procter &amp; Gamble Completes Acquisition of Ambi Pur from Sara Lee Corporation</title>
		<link>http://www.stockbloghub.com/2010/07/07/pg-procter-gamble-completes-acquisition-of-ambi-pur-from-sara-lee-corporation/42772</link>
		<comments>http://www.stockbloghub.com/2010/07/07/pg-procter-gamble-completes-acquisition-of-ambi-pur-from-sara-lee-corporation/42772#comments</comments>
		<pubDate>Wed, 07 Jul 2010 13:52:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Personal Products]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=42772</guid>
		<description><![CDATA[Procter &#38; Gamble Company (PG), a manufacturer of consumer goods, has completed its acquisition of the Ambi Pur brand from Sara Lee Corporation (SLE) for €320 million (about $470 million). Procter &#38; Gamble will pay about 12% of the total consideration into escrow account pending deferred transfers of certain assets. In February 2010, Sara Lee hedged €1.6 billion at $1.35 per euro in anticipation of proceeds to be generated by the divestiture of its Household &#38; Body Care business. This deal was initiated by Sara Lee in December 2009. The Ambi Pur acquisition enlarges Procter &#38; Gamble’s global leadership in Home Care and specifically Air Care, and will widen its base in Europe and Asia. Procter &#38; Gamble’s growth drivers include product innovation, expansion into emerging markets, and continuing cost-cutting ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/07/pg-procter-gamble-completes-acquisition-of-ambi-pur-from-sara-lee-corporation/42772/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences Seeks European Approval For Lupus Drug</title>
		<link>http://www.stockbloghub.com/2010/06/09/hgsi-human-genome-sciences-seeks-european-approval-for-lupus-drug/39731</link>
		<comments>http://www.stockbloghub.com/2010/06/09/hgsi-human-genome-sciences-seeks-european-approval-for-lupus-drug/39731#comments</comments>
		<pubDate>Wed, 09 Jun 2010 13:07:08 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=39731</guid>
		<description><![CDATA[Human Genome Sciences Inc. (HGSI) recently submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking marketing approval for its potential blockbuster lupus drug candidate, Benlysta, in Europe. Human Genome and GlaxoSmithKline plc (GSK) are co-developing Benlysta for treating patients suffering from systemic lupus erythematosus (SLE). The application includes data from the two late-stage trials, BLISS-52 and BLISS-76. Both double-blind, placebo-controlled, multi-center studies evaluated the efficacy and safety of Benlysta in combination with the standard of care against placebo plus standard of care, in seropositive SLE patients. The studies evaluated a total of 1,684 patients. We remind investors that Benlysta, a human monoclonal antibody that specifically recognizes and prevents the biological activity of B-lymphocyte stimulator (BLyS), met the primary endpoint in the BLISS-52 trial in 2009. Furthermore, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/06/09/hgsi-human-genome-sciences-seeks-european-approval-for-lupus-drug/39731/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Corporation &#8211; Earnings Estimates Are Up</title>
		<link>http://www.stockbloghub.com/2010/03/17/sle-sara-lee-corporation-earnings-estimates-are-up/30896</link>
		<comments>http://www.stockbloghub.com/2010/03/17/sle-sara-lee-corporation-earnings-estimates-are-up/30896#comments</comments>
		<pubDate>Wed, 17 Mar 2010 22:13:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30896</guid>
		<description><![CDATA[Sara Lee Corp. (SLE) is pressuring its 52-week high on an improving consumer environment and a compelling valuation, trading with a forward P/E of just 13.5X. Company Description Sara Lee Corp. manufactures and sells a range of branded food products worldwide. The Company was founded in 1939 and has a market cap of $9.8 billion. Second-Quarter Results Sales were in line with last year at $2.9 billion, but earnings came in much better than expected at 36 cents, 57% ahead of the Zacks Consensus Estimate. The company has produced solid results over the last four quarters, with an average earnings surprise of 53%. Operating income spiked from last year, jumping to $282 million from a loss $4 million last year on strong segment results and a $27 million gain on ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/17/sle-sara-lee-corporation-earnings-estimates-are-up/30896/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences Pipeline Bigger than Earnings</title>
		<link>http://www.stockbloghub.com/2010/02/25/hgsi-human-genome-sciences-pipeline-bigger-than-earnings/29027</link>
		<comments>http://www.stockbloghub.com/2010/02/25/hgsi-human-genome-sciences-pipeline-bigger-than-earnings/29027#comments</comments>
		<pubDate>Thu, 25 Feb 2010 20:31:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29027</guid>
		<description><![CDATA[Human Genome Sciences, Inc. (HGSI) is expected to report fourth quarter as well as fiscal 2009 results shortly. We expect that the company will report a loss of 10 cents per share for the fourth quarter of 2009 and 4 cents for fiscal 2009. However, we believe that the earnings report is basically a non-event for the company and will have little or no impact on the stock price. We feel that investors are more concerned about the progress of the company’s pipeline candidates, especially Benlysta. Human Genome boasts a robust pipeline with three late-stage candidates. Human Genome Sciences intends to seek approval for its potential blockbuster lupus drug candidate Benlysta during the second quarter of 2010 in the United States and Europe. We expect US approval in early 2011. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/25/hgsi-human-genome-sciences-pipeline-bigger-than-earnings/29027/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Corporation &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2010/02/23/sle-sara-lee-corporation-bull-of-the-day/28481</link>
		<comments>http://www.stockbloghub.com/2010/02/23/sle-sara-lee-corporation-bull-of-the-day/28481#comments</comments>
		<pubDate>Wed, 24 Feb 2010 03:57:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=28481</guid>
		<description><![CDATA[We still hold an Outperform rating on Sara Lee (SLE) shares to reflect our favorable view of management&#8217;s various initiatives to achieve growth and streamline operations. The company&#8217;s Transformation Plan is expected to generate sales growth in the range of 4% to 5% and earnings growth in the range of 5% to 8% by next year. Further, the company is executing a series of global projects to generate cost savings in the range of $350 million to $400 million by fiscal 2012. The company is focused on more attractive product lines that have better potential for profitable growth in the long-term. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/23/sle-sara-lee-corporation-bull-of-the-day/28481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PTIE) Eleven stocks to watch: February 22, 2010</title>
		<link>http://www.stockbloghub.com/2010/02/23/ptie-eleven-stocks-to-watch-february-22-2010/28476</link>
		<comments>http://www.stockbloghub.com/2010/02/23/ptie-eleven-stocks-to-watch-february-22-2010/28476#comments</comments>
		<pubDate>Wed, 24 Feb 2010 03:55:13 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[DTS Inc.]]></category>
		<category><![CDATA[DTSI]]></category>
		<category><![CDATA[ELGX]]></category>
		<category><![CDATA[Endologix Inc]]></category>
		<category><![CDATA[Integrated Silicon Solution Inc]]></category>
		<category><![CDATA[ISSI]]></category>
		<category><![CDATA[LANC]]></category>
		<category><![CDATA[Lancaster Colony Corporation]]></category>
		<category><![CDATA[MEND]]></category>
		<category><![CDATA[Micrus Endovascular Corporation]]></category>
		<category><![CDATA[Pain Therapeutics Inc.]]></category>
		<category><![CDATA[PBIB]]></category>
		<category><![CDATA[Perrigo Company]]></category>
		<category><![CDATA[Porter Bancorp Inc.]]></category>
		<category><![CDATA[PRGO]]></category>
		<category><![CDATA[PTIE]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=28476</guid>
		<description><![CDATA[Each weekend I use Barchart to screen for a list of stocks that I think may be of interest to my readers in the coming week. I am not recommending these stocks, I just want to share with you a screening process and it&#8217;s up to you to do further research and see if there is a place in your portfolio for these issues. I start with the list of stocks hitting new highs and lows for the last 20 days and sort for frequency. I then take the top 10 from each list that have hit new milestones in at least 50% of the last 20 sessions. That list of the 10 top gainers and 10 top losers is where I start. I put them all in a test ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/23/ptie-eleven-stocks-to-watch-february-22-2010/28476/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee&#8217;s Earnings Beat Expectations</title>
		<link>http://www.stockbloghub.com/2010/02/04/sle-sara-lees-earnings-beat-expectations/27010</link>
		<comments>http://www.stockbloghub.com/2010/02/04/sle-sara-lees-earnings-beat-expectations/27010#comments</comments>
		<pubDate>Thu, 04 Feb 2010 21:43:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=27010</guid>
		<description><![CDATA[Sara Lee Corp. (SLE) reported strong operating income growth for the second quarter of fiscal 2010, driven by significant improvement in operating segment income across the company, particularly in the North American Retail and International Beverage business segments, and lower corporate expenses. Net income was $66 million in the second quarter versus $23 million in the year-ago period. EPS was 43 cents compared to a loss of 6 cents during the same period of fiscal 2009. Reported EPS was well above the Zacks Consensus Estimate of 23 cents. Net sales of $2.9 billion were same as the year-ago period as the favorable foreign currency exchange rate gains were partially offset by the impact of divestitures, slightly lower unit volumes, and lower selling prices. Total Sara Lee unit volumes increased by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/04/sle-sara-lees-earnings-beat-expectations/27010/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences to Seek Drug Approval in Second Quarter</title>
		<link>http://www.stockbloghub.com/2010/01/14/hgsi-human-genome-sciences-to-seek-drug-approval-in-second-quarter/24981</link>
		<comments>http://www.stockbloghub.com/2010/01/14/hgsi-human-genome-sciences-to-seek-drug-approval-in-second-quarter/24981#comments</comments>
		<pubDate>Thu, 14 Jan 2010 19:14:07 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24981</guid>
		<description><![CDATA[Human Genome Sciences Inc. (HGSI) announced recently that it intends to seek approval for its potential blockbuster lupus drug candidate Benlysta during the second quarter of 2010 in the United States and Europe. Human Genome and GlaxoSmithKline plc (GSK) are co-developing Benlysta for treating patients suffering from systemic lupus erythematosus (SLE). We remind investors that in Nov 2009, Benlysta met the primary end-point in BLISS-76, a pivotal phase III study, through 52 weeks. BLISS-76 is the second phase III trial in seropositive SLE patients. Complete 76-week data from the trial are expected to be available in the second quarter of 2010. Positive results from the first trial, BLISS-52, were announced in the third quarter of 2009. These results bring the company a step closer to becoming the first to have ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/14/hgsi-human-genome-sciences-to-seek-drug-approval-in-second-quarter/24981/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLE) Sara Lee Corporation &#8211; Earnings Estimates Advance</title>
		<link>http://www.stockbloghub.com/2009/12/27/sle-sara-lee-corporation-earnings-estimates-advance/23567</link>
		<comments>http://www.stockbloghub.com/2009/12/27/sle-sara-lee-corporation-earnings-estimates-advance/23567#comments</comments>
		<pubDate>Sun, 27 Dec 2009 23:21:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Processed & Packaged Goods]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23567</guid>
		<description><![CDATA[Sara Lee Corp. (SLE) gapped open on its strong Q1 results from early November on lower costs and strong North American sales, driving shares to a new 52-weke high above $12. Company Description Sara Lee develops and manufactures a wide range of branded packaged food products under brands like Sara Lee, Ball Park and Jimmy Dean worldwide. The company was founded in 1939 and has a market cap of $8.61 billion. Shares of SLE have posted big gains this year, rallying with the market after bottoming out in early March. The company&#8217;s first-quarter results, reported on Nov 4, gave shares an extra boost. First-Quarter Results Sales were down 7.4% from last year to $2.6 billion. But earnings came in better than expected at 32 cents, 15 cents ahead of the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/27/sle-sara-lee-corporation-earnings-estimates-advance/23567/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PG) The Procter &amp; Gamble Company Acquires Ambi Pur Brand From Sara Lee Corporation</title>
		<link>http://www.stockbloghub.com/2009/12/17/pg-the-procter-gamble-company-acquires-ambi-pur-brand-from-sara-lee-corporation/23160</link>
		<comments>http://www.stockbloghub.com/2009/12/17/pg-the-procter-gamble-company-acquires-ambi-pur-brand-from-sara-lee-corporation/23160#comments</comments>
		<pubDate>Fri, 18 Dec 2009 01:05:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Consumer Goods]]></category>
		<category><![CDATA[Personal Products]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[Warner Chilcott Limited]]></category>
		<category><![CDATA[WCRX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23160</guid>
		<description><![CDATA[The Procter &#38; Gamble Company (PG) signed an agreement to acquire the Ambi Pur Brand from Sara Lee Corporation (SLE) for €320 million ($470 million). Ambi Pur is a leading global air care brand with several toilet care products. The company has strong a presence in Western Europe and Asia. The Ambi Pur brand generated annual sales of approximately €260 million ($355 million) for fiscal 2009. The acquisition of Ambi Pur strengthens Procter and Gamble’s global leadership business in Home Care, especially Air Care by reaching out to more consumers worldwide. This acquisition not only brings in the strong Ambi Pur brand equity, but also provides geographic presence particularly in Europe and Asia. Moreover, the Ambi Pur brand acquisition adds high-performance products and new technologies to the company’s current Air ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/17/pg-the-procter-gamble-company-acquires-ambi-pur-brand-from-sara-lee-corporation/23160/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(NWSA) Q4 S&amp;P Earnings to More than Double &#8211; Earnings Trends</title>
		<link>http://www.stockbloghub.com/2009/12/08/nwsa-q4-sp-earnings-to-more-than-double-earnings-trends/22213</link>
		<comments>http://www.stockbloghub.com/2009/12/08/nwsa-q4-sp-earnings-to-more-than-double-earnings-trends/22213#comments</comments>
		<pubDate>Tue, 08 Dec 2009 18:16:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Entertainment - Diversified]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Campbell Soup Company]]></category>
		<category><![CDATA[CPB]]></category>
		<category><![CDATA[IFF]]></category>
		<category><![CDATA[International Flavors & Fragrances Inc]]></category>
		<category><![CDATA[News Corporation]]></category>
		<category><![CDATA[NWSA]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SJM]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[The J. M. Smucker Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22213</guid>
		<description><![CDATA[Key Points: •    Earnings Surprise Ratio (#beat/#miss) at 5.28, almost double normal •    Median Earnings Surprise 7.14%, very strong •    Year-over-year Earnings Growth Ratio (# Pos Growth/# Neg Growth) at 0.81 •    Sales Surprise Ratio at 1.45 •    Sales Growth Ratio at just 0.43 •    Total Net Income for S&#38;P 500 reported  is 11.1% below a year ago, 10.7% above what was earned in 2Q09 •    Total S&#38;P 500 Revenues reported down 10.8% year over year, up 3.6% from 2Q09 •    2009 Earnings Revisions ratio for full S&#38;P 500 falls to 2.42, down from 3.00 two weeks ago (report was not run due to Thanksgiving last week), still very high •    2010 ratio at 1.77, down from 1.98 two weeks ago •    S&#38;P500 expected to earn $574.1 billion in 2008, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/08/nwsa-q4-sp-earnings-to-more-than-double-earnings-trends/22213/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences to Sell 12.5 Million Shares</title>
		<link>http://www.stockbloghub.com/2009/12/02/hgsi-human-genome-sciences-to-sell-12-5-million-shares/21745</link>
		<comments>http://www.stockbloghub.com/2009/12/02/hgsi-human-genome-sciences-to-sell-12-5-million-shares/21745#comments</comments>
		<pubDate>Wed, 02 Dec 2009 20:38:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21745</guid>
		<description><![CDATA[Human Genome Sciences Inc. (HGSI) announced that it intends to sell up to 12.5 million shares to raise money for the development of its potential blockbuster lupus drug Benlysta and other business activities. The net proceeds from the public offering will be used for general corporate purposes, which include the acquisition of additional manufacturing capacity and development of new indications for Benlysta. The underwriters of the offering have a 30-day option to purchase another 1.9 million shares to cover over-allotments. Human Genome forecasted its operating expenses, after collaboration partner reimbursements, to increase from $250 million in 2009 to a range of about $325 million- $375 million in 2010. The increase is primarily attributable to the pre-launch manufacturing expenses associated with Benlysta coupled with increased sales and marketing expenses. As a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/02/hgsi-human-genome-sciences-to-sell-12-5-million-shares/21745/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences Begins Trial</title>
		<link>http://www.stockbloghub.com/2009/11/25/hgsi-human-genome-sciences-begins-trial/21294</link>
		<comments>http://www.stockbloghub.com/2009/11/25/hgsi-human-genome-sciences-begins-trial/21294#comments</comments>
		<pubDate>Wed, 25 Nov 2009 18:17:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21294</guid>
		<description><![CDATA[Recently, Human Genome Sciences, Inc. (HGSI) and Aegera Therapeutics announced the initiation of dosing in a phase I clinical trial to evaluate the safety and tolerability of its lead inhibitor-of-apoptosis protein (IAP), HGS1029, as monotherapy in patients with advanced lymphoid tumors. An additional phase I clinical trial of the compound is being conducted to evaluate its safety and tolerability in patients with advanced solid tumors. Earlier in December 2007, Human Genome acquired exclusive worldwide rights (excluding Japan) to develop and commercialize HGS1029 and other IAPs from Aegera Therapeutics. The primary objectives of the phase I open-label, dose-escalation study include the evaluation of safety and tolerability of HGS1029 as monotherapy in patients with advanced lymphoid tumors and selection of a recommended dose for further studies. In addition, secondary objectives include studying ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/25/hgsi-human-genome-sciences-begins-trial/21294/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGSI) Human Genome Sciences Reports Lower Q3 Loss</title>
		<link>http://www.stockbloghub.com/2009/11/07/hgsi-human-genome-sciences-reports-lower-q3-loss/19795</link>
		<comments>http://www.stockbloghub.com/2009/11/07/hgsi-human-genome-sciences-reports-lower-q3-loss/19795#comments</comments>
		<pubDate>Sun, 08 Nov 2009 00:39:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19795</guid>
		<description><![CDATA[Human Genome Sciences, Inc. (HGSI) reported third quarter net loss of $49 million or 32 cents per share, in-line with the Zacks Consensus Estimate. The company reported a net loss of $74.2 million or 50 cents in the year ago quarter. The lower net loss for the quarter was primarily attributable to increased revenues from manufacturing and development services and lower operating expenses. Revenues for the quarter came in at $18.834 million which reflected an increase of 60.6%. Revenues were inclusive of $8.7 million from manufacturing and development services, $8.9 million recognized under the company’s agreement with Novartis (NVS) pertaining to hepatitis C drug Zalbin, and $1.0 million recognized under the agreement with GlaxoSmithKline plc (GSK) pertaining to the potential blockbuster lupus drug Benlysta. Research &#38; development spend declined 36% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/07/hgsi-human-genome-sciences-reports-lower-q3-loss/19795/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

